apica indole based drug acts potent agonist cannabinoid never previously reported scientific patent literature first identified laboratories japan march ingredient synthetic cannabis smoking blends along indazole derivative apinaca sold structurally closely resembles cannabinoid compounds patent wo indole core instead indazole simple pentyl chain indole given known metabolic liberation presence impurity amantadine related compound apinaca suspected metabolic hydrolysis amide group apica may also release amantadine pharmacological testing determined apica nm slightly less potent nm four times tightly binding apinaca first published synthesis pharmacological evaluation apica revealed acts full agonist nm receptors furthermore apica possesses cannabislike effects rats appears less potent potent october apica controlled substance